» Authors » Tom H Greene

Tom H Greene

Explore the profile of Tom H Greene including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 1239
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Derington C, Berchie R, Scharfstein D, Andrews R, Greene T, Xu Y, et al.
J Gerontol A Biol Sci Med Sci . 2025 Feb; PMID: 39945185
Background: Whether the differing mechanistic effects between angiotensin-2 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) on the renin-angiotensin system translate to differential effects on clinical cognitive outcomes is unclear....
2.
Cooper M, Cherney D, Greene T, Heerspink H, Jardine M, Lewis J, et al.
J Am Soc Nephrol . 2024 Aug; 35(11):1546-1557. PMID: 39150859
No abstract available.
3.
McKee K, Knighton A, Veale K, Martinez J, McCann C, Anderson J, et al.
Circ Cardiovasc Qual Outcomes . 2024 Apr; 17(5):e010477. PMID: 38567507
Background: Faster delivery of tPA (tissue-type plasminogen activator) results in better health outcomes for eligible patients with stroke. Standardization of stroke protocols in emergency departments (EDs) has been difficult, especially...
4.
Jacobs J, Derington C, Zheutlin A, King J, Cohen J, Bucheit J, et al.
J Am Heart Assoc . 2024 Jan; 13(3):e031574. PMID: 38240275
Background: Therapeutic inertia (TI), failure to intensify antihypertensive medication when blood pressure (BP) is above goal, remains prevalent in hypertension management. The degree to which self-reported antihypertensive adherence is associated...
5.
Kennedy E, Ozmen M, Bouldin E, Panahi S, Mobasher H, Troyanskaya M, et al.
J Neurotrauma . 2023 Dec; 41(7-8):924-933. PMID: 38117134
The chronic mental health consequences of mild traumatic brain injury (TBI) are a leading cause of disability. This is surprising given the expectation of significant recovery after mild TBI, which...
6.
King J, Berchie R, Derington C, Marcum Z, Scharfstein D, Greene T, et al.
J Am Heart Assoc . 2023 Aug; 12(17):e030311. PMID: 37646208
BACKGROUND Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) block distinct components of the renin-angiotensin system. Whether this translates into differential effects on cardiovascular disease events remains unclear....
7.
Rathinagopal T, Bhanot S, Yegrov S, Min J, Hu N, Fang J, et al.
Ann Surg Open . 2023 Aug; 3(1):e117. PMID: 37600093
Background: Colorectal cancer is the second leading cause of cancer-related deaths. This study demonstrates the utility of a simple blood test with high sensitivity and specificity for colorectal adenomatous polyps...
8.
Ghazi L, Shen J, Ying J, Derington C, Cohen J, Marcum Z, et al.
JAMA Netw Open . 2023 May; 6(5):e2314443. PMID: 37204788
Importance: Intensive vs standard treatment to lower systolic blood pressure (SBP) reduces risk of mild cognitive impairment (MCI) or dementia; however, the magnitude of cognitive benefit likely varies among patients....
9.
Xu Y, Greene T, Bress A, Bellows B, Zhang Y, Zhang Z, et al.
Stat Methods Med Res . 2022 Aug; 31(11):2122-2136. PMID: 35912490
Evidence from observational studies has become increasingly important for supporting healthcare policy making via cost-effectiveness analyses. Similar as in comparative effectiveness studies, health economic evaluations that consider subject-level heterogeneity produce...
10.
Cohen J, Marcum Z, Zhang C, Derington C, Greene T, Ghazi L, et al.
JAMA Netw Open . 2022 Jul; 5(7):e2220680. PMID: 35834254
Importance: The cardiovascular and renal outcomes of angiotensin-II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatment are well-known; however, few studies have evaluated initiation of these agents and cognitive...